Details for New Drug Application (NDA): 022015
✉ Email this page to a colleague
The generic ingredient in MIRALAX is polyethylene glycol 3350. There are four hundred and twenty-one drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.
Summary for 022015
Tradename: | MIRALAX |
Applicant: | Bayer Healthcare Llc |
Ingredient: | polyethylene glycol 3350 |
Patents: | 0 |
Pharmacology for NDA: 022015
Mechanism of Action | Osmotic Activity |
Physiological Effect | Stimulation Large Intestine Fluid/Electrolyte Secretion |
Suppliers and Packaging for NDA: 022015
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MIRALAX | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 022015 | NDA | Bayer HealthCare LLC. | 11523-4357 | 11523-4357-2 | 2 CARTON in 1 CARTON (11523-4357-2) / 20 PACKET in 1 CARTON / 17 g in 1 PACKET |
MIRALAX | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 022015 | NDA | Bayer HealthCare LLC. | 11523-4357 | 11523-4357-3 | 2 BOTTLE, PLASTIC in 1 PACKAGE, COMBINATION (11523-4357-3) / 578 g in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | FOR SOLUTION;ORAL | Strength | 17GM/SCOOPFUL | ||||
Approval Date: | Oct 6, 2006 | TE: | RLD: | Yes |
Complete Access Available with Subscription